This document is an excerpt from the EUR-Lex website
Document 52004XC1224(01)
Summary of Community decisions on marketing authorisations in respect of medicinal products for the period 15 November 2004 to 15 December 2004(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Summary of Community decisions on marketing authorisations in respect of medicinal products for the period 15 November 2004 to 15 December 2004(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Summary of Community decisions on marketing authorisations in respect of medicinal products for the period 15 November 2004 to 15 December 2004(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
OB C 320, 24.12.2004, p. 23–25
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
24.12.2004 |
EN |
Official Journal of the European Union |
C 320/23 |
Summary of Community decisions on marketing authorisations in respect of medicinal products for the period 15 November 2004 to 15 December 2004
(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))
(2004/C 320/13)
— |
Issuing of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93): accepted
|
— |
Modification of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93): accepted
|
— |
Withdrawal of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93)
|
— |
Modification of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93): accepted
|
(1) OJ L 214, 24.8.1993, p. 1.